Beltran BE, Quinones P, Morales D, Revilla J, Alva J, Castillo JJ. Diffuse Large B-Cell Lymphoma in Human T-Lymphotropic Virus Type-1 Carriers. Leukemia Research and Treatment, January 2012; 2012: 262363.
Wang CC, Castillo JJ. Management of HIV-Associated Lymphomas. Medicine & Health Rhode Island, January 2011; 94(1): 4-6.
Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. EBV-positive diffuse large B-cell lymphoma of the elderly: what we know so far. The Oncologist, January 2011; 16(1): 87-96.
Beltran BE, Castillo JJ, Salas R, Quinones P, Morales D, Cotrina E, Miranda RN, Sotomayor EM. Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America. Leukemia and Lymphoma, January 2011; (52)1: 153-156.
Reagan JL, Castillo JJ. Ofatumumab for untreated and relapsed/refractory chronic lymphocytic leukemia. Expert Review on Anticancer Therapy, February 2011; 11(2): 151-160.
Beltran B, Morales D, Quinones P, Cotrina E, Castillo JJ. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leukemia Research, March 2011; (35)3: 334-339.
Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F, Horwitz SM, Montoto S, Pantanowitz L, Ribera JM, Vose JM. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. American Journal of Hematology, March 2011; 86(3): 256-261.
Mazzaglia PJ, Strenger R, Castillo JJ. Extramedullary relapse of acute myeloid leukemia in a surgical wound. Leukemia and Lymphoma, March 2011; 52(3): 541-543.
Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. HIV-negative plasmablastic lymphoma: not in the mouth. Clinical Lymphoma, Myeloma & Leukemia, April 2011; 11(2): 185-189.
Beltran BE, Castillo JJ, Morales D, Hurtado de Mendoza F, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru. American Journal of Hematology, August 2011; 86(8): 663-667.
Castillo JJ, Sinclair N, Stachurski D, Jacobsen ED. Positive HIV ELISA test, autoimmune hemolytic anemia and generalized lymphadenopathy: A unifying diagnosis. American Journal of Hematology, August 2011; 86(8): 690-693.
Jabbour M, Tuncer H, Castillo JJ, Butera JN, Roy T, Pojani J, Al-Malki M, Al-Homsi S. Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/ Lymphoma: A Review. Bone Marrow Transplantation, August 2011; 46(8): 1039-1044.
Castillo JJ, Dalia S, Shum H. Meta-analysis on the association between cigarette smoking and incidence of Hodgkin's lymphoma. Journal of Clinical Oncology, October 2011; 29(29): 3900-3906.
Castillo JJ. Plasmablastic lymphoma: are more intensive therapies needed? Leukemia Research, December 2011; 35(12): 1547-1548.
Beltran BE, Morales D, Quinones P, Medeiros LJ, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma in young immunocompetent individuals. Clinical Lymphoma, Myeloma & Leukemia, December 2011; 11(6): 512-516.
Beltran BE, Morales D, Quinones P, Miranda RN, Goswami M, Castillo JJ. Peripheral T-Cell Lymphoma with a Regulatory T-Cell Phenotype: Report of a Nodal and an Extranodal Case from Peru. Applied Immunohistochemistry & Molecular Morphology. August 10 2011 [Epub ahead of print]
Castillo JJ, Furman M, Winer ES. CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opinion on Investigational Drugs. November 24 2011 [Epub ahead of print]
Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. The Scientific World Journal, March 2011; (11): 687-696.
Berz D, Castillo JJ, Quilliam DN, Colvin G. Pesticides and non-Hodgkin lymphoma: An overview for the clinician. Medicine & Health Rhode Island, January 2011; 94(1): 10-12.
Castillo J, Perez K. The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies. Journal of Blood Medicine, February 2010; 1(1): 1-8.
Dalia S, Milani C, Castillo J, Mega A, Schiffman F. Fooled by the fragments: Masquerading microangiopathy. Medicine & Health Rhode Island, January 2010; 93(1): 25-26.
Morales D, Beltran B, Hurtado de Mendoza F, Riva L, Yabar A, Quinones P, Butera JN, Castillo J. EBV as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leukemia and Lymphoma, January 2010; 51(1): 66-72.
Perez K, Castillo J, Dezube BJ, Pantanowitz L. HIV-associated anaplastic large cell lymphoma. Leukemia and Lymphoma, March 2010; 51(3): 430-438.
Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Prognostic factors in chemotherapy treated patients with HIV-associated plasmablastic lymphoma. The Oncologist, March 2010; 15(3): 293-299.
Castillo JJ, Morales D, Quinones P, Cotrina E, Beltran B. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leukemia and Lymphoma, October 2010; 51(10): 1822-1828.
Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and the development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood, October 2010; 116(16): 2897-2907.
Castillo JJ, Rizack T, Treaba D. Immunophenotypical switch versus tumor heterogeneity in a patient with HIV-associated diffuse large B-cell lymphoma. Pathology Research International, October 2010; 2011: 563216.
Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Clinical and pathological differences between HIV-positive and HIV-negative patients with plasmablastic lymphoma. Leukemia and Lymphoma, November 2010; 51(11): 2047-2053.
Alduaij A, Butera JN, Treaba D, Castillo JJ. Complete Remission in Two Cases of Adult T-Cell Leukemia/Lymphoma Treated With Hyper-CVAD: A Case Report and Review of the Literature. Clinical Lymphoma, Myeloma & Leukemia, December 2010; 10(6): 480-483.
Layton J, Castillo JJ. Non-AIDS-defining cancers. Medicine & Health Rhode Island, October 2010; 93(10): 296-299.
Beltran B, Winer E, Castillo J. ALK-positive diffuse large B-cell lymphoma: An aggressive clinicopathological entity. European Journal of Clinical & Medical Oncology, February 2010; 2(1): 155-161.
Pantanowitz L, Castillo J, Freeman J, Dezube B. Images in HIV/AIDS. Fatal HIV-associated anaplastic large-cell lymphoma. The AIDS Reader, January 2009; 19(1): 19-21.
Beltran B, Castillo J, Salas R, Quinones P, Morales D, Hurtado F, Riva L, Winer E. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Journal of Hematology & Oncology, February 2009; 2(1): 11.
Milani C, Castillo J. Veltuzumab, an anti-CD20 monoclonal antibody for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura. Current Opinion in Molecular Therapeutics, April 2009; 11(2): 200-207.
Castillo J, Perez K, Milani C, Pantanowitz L, Dezube B. HIV-associated peripheral T-cell lymphoma: A comprehensive review. Journal of HIV Therapy, June 2009; 14(2): 34-40.
Beltran B, Salas R, Quinones P, Morales D, Hurtado F, Cotrina E, Riva L, Castillo J. EBV-positive diffuse large B-cell lymphoma in a HTLV-I carrier. Infectious Agents and Cancer, July 2009; 4(1): 10.
Hebert H, Butera JN, Castillo J, Mega AE. Are we training our fellows adequately in delivering bad news to patients? A survey of Hematology/Oncology Program Directors. Journal of Palliative Medicine, December 2009; 12(12): 1119-1124.
Rizack T, Mega A, Legare R, Castillo J. Management of hematological malignancies during pregnancy. American Journal of Hematology, December 2009; 84(12): 830-841.
Castillo J, Milani C, Mendez D. Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders. Expert Opinion on Investigational Drugs, April 2009; 18(4): 491-500.
Castillo J, Dezube B, Pantanowitz L. Plasmablastic lymphoma in HIV: Lessons learned from 112 published cases. American Journal of Hematology, October 2008; 83(10): 804-809.
Castillo J, Hansen C, Mega A, Tashima K. AIDS-related lymphomas: The Rhode Island experience. Medicine & Health Rhode Island, November 2008; 91(11): 332-334.
Mitri J, Castillo J, Pittas A. Diabetes and risk of non-Hodgkin lymphoma: A meta-analysis of observational studies. Diabetes Care, December 2008; 31(12): 2391-2397.
Castillo J, Winer E, Quesenberry P. Newer monoclonal antibodies for hematological malignancies. Experimental Hematology, July 2008; 36(7): 755-768.
Castillo J, Dezube B, Pantanowitz L. Noteworthy features of HIV-associated T-cell lymphoma. HIV & AIDS Review, December 2007; 6(4): 26-30.